Literature DB >> 18294313

Acute myeloid dendritic cell leukaemia with specific cutaneous involvement: a diagnostic challenge.

M Ferran1, F Gallardo, A M Ferrer, A Salar, E Pérez-Vila, N Juanpere, R Salgado, B Espinet, A Orfao, L Florensa, R M Pujol.   

Abstract

Myeloid or type 1 dendritic cell leukaemia is an exceedingly rare haematopoietic neoplasm characterized by a specific immunophenotypic profile close to plasmacytoid dendritic cell and acute myelogenous leukaemia. A 77-year-old man presenting specific cutaneous infiltration by myeloid dendritic cell leukaemia is reported. The clinical features as well as the cutaneous histopathological and immunohistochemical features led to the initial diagnosis of CD4+/CD56+ haematodermic neoplasm. However, extensive immunophenotypic studies performed from peripheral blood blasts disclosed that leukaemic cells expressed myeloid dendritic cell markers, confirming the diagnosis. The diagnostic difficulties of specific cutaneous involvement by myeloid dendritic cell leukaemia on the basis of routine histopathological and immunohistochemical features are highlighted.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18294313     DOI: 10.1111/j.1365-2133.2008.08480.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  3 in total

1.  Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study.

Authors:  Livio Pagano; Caterina Giovanna Valentini; Alessandro Pulsoni; Simona Fisogni; Paola Carluccio; Francesco Mannelli; Monia Lunghi; Gianmatteo Pica; Francesco Onida; Chiara Cattaneo; Pier Paolo Piccaluga; Eros Di Bona; Elisabetta Todisco; Pellegrino Musto; Antonio Spadea; Alfonso D'Arco; Stefano Pileri; Giuseppe Leone; Sergio Amadori; Fabio Facchetti
Journal:  Haematologica       Date:  2012-10-12       Impact factor: 9.941

2.  Blastic plasmacytoid dendritic cell leukemia successfully treated by autologous hematopoietic stem cell transplantation to a remission of 48-month duration.

Authors:  Deniz Goren Sahin; Olga Meltem Akay; Hava Usküdar Teke; Neslihan Andıc; Eren Gunduz; Zafer Gulbas
Journal:  Case Rep Hematol       Date:  2013-12-11

3.  Diagnostic challenges of CD4+/CD56+/CD123+ hematological neoplasms.

Authors:  Leandro S Thiago; Alex Freire Sandes
Journal:  An Bras Dermatol       Date:  2013 Jul-Aug       Impact factor: 1.896

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.